Skip to content
Screener

Ardelyx ARDX Total Cost of Revenue

Total Cost of Revenue at other companies

Amgen logo
AmgenAMGN
$2.81B-6.6%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$584M-8.0%
AbbVie logo
AbbVieABBV
$4.29B-1.3%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$9.53M+28.4%
XER
Xeris Biopharma Holdings, Inc.XERS
$12.51M+5.2%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$13.8M+50.0%

Other financials

Income statement

See full
Revenue$120.9M+23.8%
Gross profit$115.1M+35.0%
Operating income-$12.4M+13.7%
Net income-$16.7M+12.4%
EPS (diluted)-$0.07+12.5%

Balance sheet

See full
Cash & equivalents$97.2M+7.9%
Total debt$256.2M+24.0%
Total equity$149.0M+6.8%
Total assets$575.9M+23.4%

Cash flow

See full
Operating cash flow-$6.4M+74.7%
CapEx$13.0K-98.0%
Free cash flow-$6.4M+75.3%

Valuation

See full
Market cap$1.2B-4.0%
Enterprise value$1.36B-0.6%
P/S2.7×-0.6×

Profitability

See full
Gross margin94.4%+9.6pp
Operating margin-25.4%
Net margin-12.4%
FCF margin-40.9%

Returns & leverage

See full
Return on equity-38.6%
Debt / equity1.7×+0.2×
Current ratio3.3×-1.0×

Where this comes from

Reported directly by Ardelyx in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.

The source filing: Ardelyx’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:12 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001437402-26-000044
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Non-cash royalty revenue related to the sale of future royalties6761,3801,3712,406
Total revenues120,87797,662215,350171,776
Costs and operating expenses
Cost of sales5,75912,40310,57024,706
Research and development26,10315,66646,29130,604
Selling, general and administrative101,44083,988203,707167,210
Total costs and operating expenses133,302112,057260,568222,520
Loss from operations(12,425)(14,395)(45,218)(50,744)

Item 1. Financial Statements (Unaudited)

FAQ

What is Ardelyx's total cost of revenue?
Ardelyx (ARDX) reported total cost of revenue of $5.76M in Q2 2026.
How has Ardelyx's total cost of revenue changed year-over-year?
Ardelyx's total cost of revenue decreased by 53.6% year-over-year, from $12.4M to $5.76M.
What is the long-term trend for Ardelyx's total cost of revenue?
Over 4 years (2021 to 2025), Ardelyx's total cost of revenue has grown at a 150.8% compound annual growth rate (CAGR), from $1M to $39.54M.
What does total cost of revenue mean?
The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.

Ask your AI about Ardelyx's total cost of revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude